About the Toxin Sequestration Theory
1.0 A New Hypothesis
The Toxin Sequestration Theory (TST) proposes a fundamentally different way of thinking about cancer. Rather than viewing tumors solely as pathological growths, TST proposes that they may represent an adaptive biological response—a mechanism by which the body isolates potentially harmful substances to protect more vital tissues from damage.
If this hypothesis proves correct, it could reshape approaches to cancer prevention, diagnosis, treatment, and environmental health.
TST has not yet been scientifically established. This page attempts to faithfully present the theory as proposed by its originator, Dr. Patrick Coles, and explains some of the observations, reasoning, and testable predictions underlying it. For Coles' views in his own words, please refer to the links to his writings in Sections 2.0 and 5.0 below.
Life survives not because it is perfect, but because it adapts. Cells repair damaged DNA. Bones remodel under stress. The immune system isolates infection. The liver processes toxins. Biology is filled with protective mechanisms that preserve life under adverse conditions. TST begins with a challenging question:
What if we have correctly observed what the body is doing by forming tumors, but misunderstood why it is doing it?
For more than a century, cancer research has been based on a prevailing model in which normal cells acquire mutations and other abnormalities, escape normal regulatory controls, and proliferate into malignant tumors. This work has produced a remarkable infrastructure of diagnosis, surgery, radiation therapy, chemotherapy, immunotherapy, and targeted treatments consistent with that model.
TST challenges a more fundamental assumption: that tumor formation itself is simply a pathological process.
According to TST, a tumor may instead be a structure created by the body in response to an underlying toxic burden—a biological vault that concentrates and isolates potentially harmful substances to protect more vital tissues.
This idea does not deny that the underlying condition giving rise to tumors may itself be life-threatening. The presence of a tumor can therefore be dangerous while still serving an adaptive biological purpose. TST asks whether the body’s formation of tumors may be more analogous to an emergency containment system than an invading enemy. It also asks us to distinguish between the underlying condition and the biological response the body creates in an effort to survive it.
2.0 The Origin of the Hypothesis
The Toxin Sequestration Theory was proposed by physicist and artificial intelligence researcher Dr. Patrick Coles. It emerged from his consideration of multiple lines of inquiry involving environmental toxicology, systems biology, cancer research, and related fields.
One important influence was the work of MIT Senior Research Scientist Stephanie Seneff. Her investigations involving deuterium, oxidative stress, environmental exposures, and cancer, contributed to Coles' thinking about whether tumors might perform a previously unrecognized physiological function.
Seneff did not propose TST. Rather, her work helped prompt Coles to reconsider the biological meaning of tumor formation and to ask a deceptively simple question:
What substances do tumors contain, and why?
That change in perspective lies at the heart of TST.
Over the course of developing the theory, Coles has examined an extensive body of published scientific literature spanning environmental toxicology, cancer biology, systems biology, and related disciplines. From that work emerged a model in which tumor formation, tissue specificity, recurrence, and what is conventionally described as metastasis may be different manifestations of an underlying biological response to toxic burden.
Readers wishing to explore the theory in greater depth are encouraged to read Patrick Coles' Substack TST Overview.
3.0 The Central Hypothesis
At its core, TST proposes that when the body's ordinary mechanisms for processing, eliminating, or otherwise managing potentially harmful substances become insufficient, the body may construct specialized biological containment structures—or “biological vaults”—in which those substances can be concentrated and isolated.
In this model, a tumor is not merely a mass of abnormal cells growing without biological purpose. It is an adaptive structure formed in response to an underlying toxic burden.
The analogy to a containment system is important. When a dangerous substance cannot immediately be eliminated, isolating it may be preferable to allowing it to circulate freely or accumulate in a more vulnerable location. TST proposes that tumor formation may represent a biological version of this strategy.
This leads to a fundamentally different interpretation of the relationship between the tumor and the underlying condition. The tumor itself may not be the original problem. Rather, it may be part of the body's response to a problem that already exists.
If the biological vault is removed or destroyed while the underlying toxic burden remains, the reason for sequestration has not necessarily disappeared. The body may therefore need to create another containment site.
This possibility becomes particularly important in understanding recurrence, multiple tumors, and what conventional oncology describes as metastatic disease.
4.0 An Alternative Explanation of Metastasis
TST challenges the conventional interpretation of metastasis.
The prevailing model holds that malignant cells escape from a primary tumor, travel through the bloodstream or lymphatic system, and establish secondary tumors elsewhere in the body.
TST proposes an alternative interpretation: additional tumors may arise because the underlying toxic burden remains unresolved and the body creates additional biological vaults to contain it.
Under this model, the appearance of another tumor does not necessarily mean that the original tumor has “spread” and created it. Instead, both tumors may represent responses to the same underlying physiological problem.
This interpretation leads to an important prediction. If secondary tumors arise as additional sequestration sites, their locations should not be arbitrary. They should tend to occur in tissues capable of accepting, processing, tolerating, or containing the particular substances involved.
That prediction connects TST's interpretation of metastasis directly to another central feature of the theory: tissue-specific sequestration.
5.0 Tissue-Specific Sequestration
One of the more intriguing aspects of TST concerns why different cancers preferentially arise in different organs and why secondary tumors appear in characteristic locations. Tumor formation and what is conventionally described as metastasis are not random processes. Certain cancers develop preferentially in particular tissues, while secondary tumors exhibit recognizable patterns of organ involvement. TST asks whether these patterns may reflect tissue-specific toxin sequestration.
According to TST, different organs and tissues may possess differing capacities to transport, concentrate, process, tolerate, or isolate particular classes of toxic substances. If so, the location of a tumor may reflect where the body is best able to sequester a particular toxic burden.
This possibility has led Patrick Coles to describe an expanded form of the hypothesis as the Tissue-Specific Toxin Sequestration Theory (TSTST). Under this interpretation, the location of a tumor is not incidental. It may provide information about both the nature of the substances being sequestered and the biological characteristics that make a particular tissue suitable for containing them.
Tissue specificity is also closely connected to TST's alternative explanation of metastasis discussed in Section 4.0. If additional tumors represent additional sequestration sites rather than simply the spread of malignant cells from a primary tumor, their characteristic locations become particularly significant. TST predicts that additional tumors should tend to arise in tissues suited to accepting or containing the particular toxic burden involved.
These proposed tissue-specific relationships generate important testable predictions. If different substances preferentially accumulate within tumors arising in different organs, careful chemical analysis of tumor specimens should reveal reproducible patterns. Those patterns could be compared among tumor types, with surrounding healthy tissue and other biological samples, and ultimately with possible environmental, occupational, dietary, pharmaceutical, metabolic, or other sources of exposure.
If such patterns exist, they could provide important evidence about the relationship among toxic burden, tumor composition, and tumor location—and help determine whether tissue-specific sequestration is actually occurring.
6.0 Why TST Matters
If TST is substantially correct, its implications extend well beyond a different explanation of tumor formation. Modern cancer treatment focuses heavily on destroying, removing, or controlling tumors. TST asks whether doing so may sometimes eliminate the body's containment structure without eliminating the underlying condition that caused the body to create it. That leads to another question:
What happens to the substances being sequestered when the tumor is removed or destroyed?
If the underlying toxic burden remains, the body may continue to face the same physiological problem, only now without that location to sequester it. According to TST, recurrence or the formation of additional tumors could therefore represent renewed attempts to contain that burden.
This would suggest an additional direction for cancer research: identifying the substances contained within tumors, determining where they came from, understanding why the body concentrated them in particular tissues, and investigating whether reducing the underlying toxic burden changes subsequent outcomes.
TST could therefore have implications for prevention as well as treatment. Environmental, occupational, dietary, pharmaceutical, metabolic, and other sources of potentially harmful substances could become important subjects of investigation.
7.0 Testing the Theory
One of TST's most important characteristics is that it makes predictions that can be tested.
Every year, millions of cancer patients throughout the world undergo surgery, with millions more undergoing biopsies and other diagnostic procedures. Many of these procedures result in tumor specimens being submitted for pathological examination. These specimens are invaluable for diagnosis and treatment planning, and modern pathology extracts an enormous amount of biological information from them. TST raises the possibility that they may also contain another largely unexplored source of information: a chemical record of the substances the body has concentrated within them.
A logical starting point is therefore straightforward: What is actually in the tumor?
Tumor tissue could be analyzed for potentially harmful substances and compared with adjacent non-tumor tissue, blood, urine, and other appropriate biological samples. Researchers could determine whether particular substances occur at elevated concentrations within tumors and whether reproducible patterns appear among particular tumor types or tissues.
If TST's tissue-specific predictions are correct, particular tumor types may contain characteristic substances or classes of substances. Those findings could then be compared with environmental, occupational, dietary, pharmaceutical, metabolic, and other potential sources of exposure. Research could progressively address increasingly specific questions:
- Are potentially harmful substances concentrated within tumors?
- Are their concentrations substantially different from surrounding tissues or other biological samples?
- Do particular substances appear preferentially in particular tumor types?
- Do those patterns correspond with the tissue-specific predictions of TST?
- Can the substances be traced to identifiable sources or exposures?
- Does reducing an identified toxic burden affect recurrence, additional tumor formation, or other outcomes?
These are empirical questions. They do not require TST to be accepted in advance. They require appropriate specimens, analytical methods, controls, and careful measurement.
This is also where Methuselean Research enters the story. TST is the first hypothesis MR intends to investigate systematically, beginning with practical ways of testing predictions such as these.
8.0 A Question Worth Answering
Throughout the history of medicine, important advances have often begun with questions that challenged long-standing assumptions. Most new hypotheses ultimately prove incomplete or incorrect. A few, however, fundamentally change our understanding of biology. Whether the Toxin Sequestration Theory belongs in that second category remains unknown.
That uncertainty is not a weakness. It is the very reason the theory should be investigated.
TST asks us to reconsider something medicine has observed for generations: the tumor itself. What if tumor formation is not simply a pathological process, but an adaptive response to an underlying toxic burden? What if the location of a tumor tells us something about the substances being contained? And what if what is conventionally described as metastasis represents the creation of additional containment structures rather than the spread of malignant cells from an original tumor?
These are consequential questions, but they are also questions that can be investigated experimentally. The significance of TST will ultimately depend not upon how compelling the theory may appear, nor upon how strongly it challenges established explanations, but upon what the evidence reveals.
Ask the question, examine the evidence, and let the evidence provide the answer.